Работы, цитирующие эту работу

Работ: 2

Работа: Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

1. CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

   Mujeeb Ur Rahman, Muhammad Bilal, Junaid Ali Shah +3

   Обзорная статьяCRISPR and Genetic EngineeringPharmaceutics2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.review-article.000012

2. Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

   Moeen F. Dababneh, Bahjat Alhasso, Abdulkareem Shareef +10

   СтатьяLipoproteins and Cardiovascular HealthJournal of Pharmaceutical Innovation2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.013240